1. Activity of aminoferrocene-based prodrugs against prostate cancer.
- Author
-
Schikora, Margot, Reznikov, Alexander, Chaykovskaya, Liudmila, Sachinska, Olga, Polyakova, Lubov, and Mokhir, Andriy
- Subjects
- *
PROSTATE cancer , *CYTOTOXINS , *CELL lines , *PRODRUGS , *CANCER cells - Abstract
We tested cytotoxicity of aminoferrocene-based prodrugs towards human androgen-responsive and unresponsive prostate cancer cell lines LNCaP and DU-145 correspondingly. Two prodrugs were selected, which are both activated at elevated concentrations of ROS with generation of quinone methide (antioxidant system inhibitor) and iron-containing compounds ( N -benzylaminoferrocene (prodrug 1 ) and Fe salts ( 2 )). We observed that only prodrug 1 is active against the selected prostate cancer cells (IC 50 = 11–27 μM) and its activity correlates with the high cell-membrane permeability and increased production of intracellular ROS. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF